Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 28, 2014 - Issue 5
Submit an article Journal homepage
1,615
Views
0
CrossRef citations to date
0
Altmetric
Article; Pharmaceutical Biotechnology

Fungal biotransformation of ezetimibe

Irfan PervaizDepartment of Pharmacy, COMSATS Institute of Information Technology, AbbottabadPakistan;Faculty of Pharmacy and Alternative Medicine, Islamia University of Bahawalpur, BahawalpurPakistan
,
Saeed AhmadFaculty of Pharmacy and Alternative Medicine, Islamia University of Bahawalpur, BahawalpurPakistan
,
Farhan Hameed KhaliqFaculty of Pharmacy and Alternative Medicine, Islamia University of Bahawalpur, BahawalpurPakistan
,
Adeel ArshadDepartment of Pharmacy, COMSATS Institute of Information Technology, AbbottabadPakistan
,
Muhammad ImranDepartment of Pharmacy, COMSATS Institute of Information Technology, AbbottabadPakistan
,
Barkat Ali KhanDepartment of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan
,
Aftab UllahDepartment of Pharmacy, COMSATS Institute of Information Technology, AbbottabadPakistan
,
Usman AliDepartment of Pharmacy, COMSATS Institute of Information Technology, AbbottabadPakistan
,
Kashif IqbalFaculty of Pharmacy, University of Balochistan, Quetta, Pakistan
,
Muhammad UsmanDepartment of Pharmacy, Abasyn University, Peshawar, Pakistan
,
Hafsa BibiDepartment of Chemistry, Gomal University, Dera Ismail Khan, Pakistan
,
Najm Ul Hassan KhanIslam College of Pharmacy, Sialkot, Pakistan
&
Wajahat MahmoodDepartment of Pharmacy, COMSATS Institute of Information Technology, AbbottabadPakistanCorrespondence[email protected]
 show all
Pages 934-940 | Received 22 Mar 2014, Accepted 26 Jun 2014, Published online: 17 Nov 2014

References

  • Patrick JE, Kosoglou T, Stauber KL, Alton, KB, Maxwell SE, Zhu Y, Statkevic P, Iannucci, Chowdhury S, Affrime M. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects. Drug Metab Dipos. 2002;30(4):430–437.
  • Van Heek M, Farley C, Compton DS, Hoos, L, Alton KB, Sybertz EJ, Davis HR. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol. 2000;129(8):1748–1754.
  • Van Heek M, France CF, Compton DS, Mcleod RL, Yumibe NP, Alton KB, Sybertz EJ, Davis HR. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther. 1997;283(1):157–163.
  • Van Heek M, Davis H. Pharmacology of ezetimibe. Eur Heart J Suppl. 2002;4(suppl J):J5–J8.
  • Jeu L, Cheng JW. Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor. Clin Ther. 2003;25(9):2352–2387.
  • Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Dipos. 2004;32(3):314–320.
  • Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 2002;106(15):1943–1948.
  • Kosoglou T, Statkevich P, Johnson-Levonas A, Paolini JF, Bergman AJ, Alton KB. Ezetimibe. Clin Pharmacokinet. 2005;44(5):467–494.
  • Pervaiz I, Ahmad S, Madni M, Ahmad H, Khaliq FH. Microbial biotransformation: a tool for drug designing. Appl Biochem Microbiol. 2013;49(5):437–450.
  • Kværnø L, Werder M, Hauser H, Carreira EM. Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption. J Med Chem. 2005;48(19):6035–6053.
  • Rosenblum SB, Huynh T, Afonso A, Davis HR, Yumibe N, Clader JW, Burnett DA. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. J Med Chem. 1998;41(6):973–980.
  • Burnett DA, Caplen MA, Davis HR Jr, Burrier RE, Clader JW. 2-Azetidinones as inhibitors of cholesterol absorption. J Med Chem. 1994;37(12):1733–1736.
  • Clader JW, Burnett DA, Caplen MA, Domalski MS, Dugar S, Vaccaro W, Sher R, Browne ME, Zhao H, Burrier RE. 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus. J Med Chem. 1996;39(19):3684–3693.
  • Gopishetty S, Louie M, Subramanian M. Microbial transformation of natural products in phytochemistry and pharmacognosy in Encyclopedia of Life Support Systems (EOLSS), Developed under the Auspices of the UNESCO. Paris: Eolss Publishers; 2011. Available from: http://www.eolss.net
  • Anaissie EJ, McGinnis MR, Pfaller MA. Clinical mycology. Elsevier Health Sciences; 2009.
  • Azerad R. Microbial models for drug metabolism. In: Faber K, editor. Biotransformations. Springer; 1999. p. 169–218.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.